• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群中的有益细菌可能导致慢性阻塞性肺疾病代谢和免疫状态的改善。

Beneficial Bacteria in the Gut Microbiota May Lead to Improved Metabolic and Immunological Status in Chronic Obstructive Pulmonary Disease.

机构信息

Departamento de Bioquímica e Biofísica, Instituto de Ciências da Saúde, Universidade Federal da Bahia, Salvador 40170-110, Bahia, Brazil.

Maternidade Climério de Oliveira (MCO/EBSERH), Universidade Federal da Bahia, Salvador 40055-150, Bahia, Brazil.

出版信息

Med Sci (Basel). 2024 Aug 16;12(3):41. doi: 10.3390/medsci12030041.

DOI:10.3390/medsci12030041
PMID:39189204
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11348168/
Abstract

UNLABELLED

The progression of chronic obstructive pulmonary disease (COPD) is characterized by functional changes in the airways. The lung-gut axis and gut microbiota (GM) have been linked to the pathophysiology of airway diseases. Regarding COPD, studies have shown that GM alterations could be related the stages of this disease. However, the relationship between GM and clinical, biochemical and immunological parameters in patients with COPD are not well understood. The aim of this study was to compare the relative abundance of specific groups of beneficial gut bacteria between COPD patients and healthy controls (CTLs) in order to evaluate relationships with metabolic and inflammatory markers in COPD.

METHODS

We included 16 stable COPD patients and 16 healthy volunteer CTLs. The relative abundances of spp. (Bf) and (Akk) bacteria and the Bacteroidetes and Firmicutes phyla were assessed by qPCR. Pulmonary function was evaluated by spirometry, biochemical parameters by colorimetric methods and plasma cytokine levels by cytometric bead array analysis.

RESULTS

The Firmicutes/Bacteroides ratio was related to emergency hospital visits and six-minute walk test (6MWT) results. Furthermore, the relative abundance of Bf was associated with plasma concentrations of glucose, triglycerides, HDL-C and IL-10. In addition, Firmicutes levels and the Firmicutes/Bacteroidetes ratio were associated with the IL-12/IL-10 ratio, while Akk abundance was linked to IL-12 levels.

CONCLUSIONS

The present findings suggest that the abundance of beneficial bacteria in the GM could influence clinical presentation and immunoregulation in COPD.

摘要

目的

本研究旨在比较 COPD 患者和健康对照(CTL)之间特定有益肠道细菌群体的相对丰度,以评估其与 COPD 中代谢和炎症标志物的关系。

方法

我们纳入了 16 例稳定期 COPD 患者和 16 例健康志愿者 CTL。通过 qPCR 评估 spp.(Bf)和 (Akk)细菌以及拟杆菌门和厚壁菌门的相对丰度。通过肺量计评估肺功能,通过比色法评估生化参数,通过流式细胞术检测分析评估血浆细胞因子水平。

结果

Firmicutes/Bacteroides 比值与急诊就诊和 6 分钟步行试验(6MWT)结果相关。此外,Bf 的相对丰度与血浆葡萄糖、甘油三酯、HDL-C 和 IL-10 浓度相关。此外,Firmicutes 水平和 Firmicutes/Bacteroidetes 比值与 IL-12/IL-10 比值相关,而 Akk 丰度与 IL-12 水平相关。

结论

本研究结果表明,GM 中有益细菌的丰度可能影响 COPD 的临床表现和免疫调节。

相似文献

1
Beneficial Bacteria in the Gut Microbiota May Lead to Improved Metabolic and Immunological Status in Chronic Obstructive Pulmonary Disease.肠道微生物群中的有益细菌可能导致慢性阻塞性肺疾病代谢和免疫状态的改善。
Med Sci (Basel). 2024 Aug 16;12(3):41. doi: 10.3390/medsci12030041.
2
Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study.肠道微生物群与慢性阻塞性肺疾病患者肺功能下降的关系:一项为期 1 年的随访研究。
Respir Res. 2022 Jan 15;23(1):10. doi: 10.1186/s12931-022-01928-8.
3
Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.肠道微生物失调导致慢性阻塞性肺疾病的发生。
Respir Res. 2021 Oct 25;22(1):274. doi: 10.1186/s12931-021-01872-z.
4
The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota Through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats.补肺健脾方通过 SCFAs/GPR43/NLRP3 通路改善 COPD 大鼠肠道黏膜免疫功能。
Int J Chron Obstruct Pulmon Dis. 2022 Jun 1;17:1285-1298. doi: 10.2147/COPD.S359428. eCollection 2022.
5
Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.急性加重期和稳定期慢性阻塞性肺疾病粪便微生物特征的变化。
Life Sci. 2021 Jan 15;265:118738. doi: 10.1016/j.lfs.2020.118738. Epub 2020 Nov 10.
6
Long-Term Erythromycin Treatment Alters the Airway and Gut Microbiota: Data from Chronic Obstructive Pulmonary Disease Patients and Mice with Emphysema.长期红霉素治疗改变气道和肠道微生物群:来自慢性阻塞性肺疾病患者和肺气肿小鼠的数据。
Respiration. 2024;103(8):461-479. doi: 10.1159/000538911. Epub 2024 Apr 26.
7
The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.特发性肺纤维化的下呼吸道微生物组和抗菌肽与慢性阻塞性肺疾病不同。
PLoS One. 2022 Jan 6;17(1):e0262082. doi: 10.1371/journal.pone.0262082. eCollection 2022.
8
Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.稳定期慢性阻塞性肺疾病、吸烟者和健康非吸烟者的社区动态与下呼吸道微生物群。
Thorax. 2016 Sep;71(9):795-803. doi: 10.1136/thoraxjnl-2015-207235. Epub 2016 May 4.
9
Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.生物恶化簇显示哮喘和慢性阻塞性肺疾病具有重叠特征,其介质和微生物组特征也不同。
J Allergy Clin Immunol. 2018 Jun;141(6):2027-2036.e12. doi: 10.1016/j.jaci.2018.04.013. Epub 2018 Apr 28.
10
Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.血清细胞因子谱分析和富集分析揭示了免疫和炎症途径在稳定期慢性阻塞性肺疾病患者中的作用。
Int J Chron Obstruct Pulmon Dis. 2014 Aug 5;9:759-73. doi: 10.2147/COPD.S61347. eCollection 2014.

引用本文的文献

1
Trends in intestinal aging: From underlying mechanisms to therapeutic strategies.肠道衰老的趋势:从潜在机制到治疗策略。
Acta Pharm Sin B. 2025 Jul;15(7):3372-3403. doi: 10.1016/j.apsb.2025.05.011. Epub 2025 May 22.
2
The Impact of Gut Microbiota on Chronic Obstructive Pulmonary Disease: A Dual-Sample Mendelian Randomization Study.肠道微生物群对慢性阻塞性肺疾病的影响:一项双样本孟德尔随机化研究
Int J Chron Obstruct Pulmon Dis. 2025 Jun 17;20:1983-1993. doi: 10.2147/COPD.S511383. eCollection 2025.

本文引用的文献

1
Analysis of Endocrine and Inflammatory Markers in Preserved Ratio Impaired Spirometry.肺功能测定比值受损时内分泌和炎症标志物的分析
Med Sci (Basel). 2024 Mar 27;12(2):18. doi: 10.3390/medsci12020018.
2
The gut microbiome as a potential source of non-invasive biomarkers of chronic obstructive pulmonary disease.肠道微生物群作为慢性阻塞性肺疾病非侵入性生物标志物的潜在来源。
Front Microbiol. 2023 Jul 25;14:1173614. doi: 10.3389/fmicb.2023.1173614. eCollection 2023.
3
Gut microbiota and chronic obstructive pulmonary disease: a Mendelian randomization study.肠道微生物群与慢性阻塞性肺疾病:一项孟德尔随机化研究
Front Microbiol. 2023 Jun 19;14:1196751. doi: 10.3389/fmicb.2023.1196751. eCollection 2023.
4
Elevated Blood Glucose is Associated with Severe Exacerbation of Chronic Obstructive Pulmonary Disease.高血糖与慢性阻塞性肺疾病的严重恶化有关。
Int J Chron Obstruct Pulmon Dis. 2022 Oct 1;17:2453-2459. doi: 10.2147/COPD.S378259. eCollection 2022.
5
The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs.人类肠道微生物群与葡萄糖代谢:关键细菌及短链脂肪酸潜在作用的综述
Am J Clin Nutr. 2022 Oct 6;116(4):862-874. doi: 10.1093/ajcn/nqac217.
6
Chronic obstructive pulmonary disease is associated with a higher risk of functional gastrointestinal disorders.慢性阻塞性肺疾病与功能性胃肠疾病的较高风险相关。
Respir Med. 2022 Jun;197:106833. doi: 10.1016/j.rmed.2022.106833. Epub 2022 Apr 7.
7
Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study.肠道微生物群与慢性阻塞性肺疾病患者肺功能下降的关系:一项为期 1 年的随访研究。
Respir Res. 2022 Jan 15;23(1):10. doi: 10.1186/s12931-022-01928-8.
8
Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.肠道微生物失调导致慢性阻塞性肺疾病的发生。
Respir Res. 2021 Oct 25;22(1):274. doi: 10.1186/s12931-021-01872-z.
9
Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity.慢性阻塞性肺疾病不同严重程度患者肠道微生物群的综合分析。
PLoS One. 2021 Apr 9;16(4):e0249944. doi: 10.1371/journal.pone.0249944. eCollection 2021.
10
Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases.探索微生物群成员双歧杆菌在调节免疫相关疾病中的作用。
Emerg Top Life Sci. 2017 Nov 30;1(4):333-349. doi: 10.1042/ETLS20170058.